Dynavax Technologies (DVAX) Stock Price
$9.41 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
4 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Dynavax Technologies, AI stock picks, stock alerts and much more.
DVAX AI Stock Analysis
Financial Performance
Dynavax Technologies has shown a strong financial performance with revenue of $80.6M in the last quarter, marking an increase of 9.3% from the previous quarter and a significant rise of 45% year over year. The gross profit stands at $67.5M, also up by 9.3% QoQ and by 44% YoY, indicating effective cost management strategies. Their operating income profit was $10.1M, which is up by an impressive rate of 66.4% QoQ and a whopping increase of about three times YoY (218.7%). The EBITDA ratio is at a decent level of 0.13.
Stock Price
The stock price currently stands at $13.05, showing an upward trend with an increase of 4.6% in the last month and a moderate rise of about 2.4% YoY which may suggest investor confidence in the company's future performance.
The RSI value is currently at around mid-range (62) suggesting neither overbought nor oversold conditions while trading above its long-term moving average ($11), indicating that it's on an uptrend.
Alternative Data Signals
Dynavax Technologies' web traffic shows promising growth with estimated monthly visitors increasing by almost double MoM (97%), indicating increased interest or engagement with their products or services.
The number of job openings has risen significantly both MoM and YoY (50%) possibly pointing to expansion plans or growth prospects for Dynavax Technologies.
A majority chunk (78%) employees report having a positive business outlook suggesting employee satisfaction and optimism regarding company's future.However, there has been a slight decrease in the social media followers on Twitter over the last 90 days (-3.5%).
Conclusion
In conclusion, Dynavax Technologies' stock shows bullish signs considering its strong financial performance and positive alternative data signals such as web traffic and job postings. However, a slight decline in their social media following may be an area of concern.
Note: This AI Stock Analysis is based on data as of February 03. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Dynavax Technologies (DVAX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Dynavax Technologies (DVAX), currently trading at $9.41, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About DVAX
-
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States.
-
Symbol
DVAX
-
Market
NASDAQ
-
Industry
Drug Manufacturers - Specialty & Generic
-
Market Cap
1.1B
Similar Stocks
 |
TherapeuticsMD TXMD |
$1.46 4.3% |
3 |
 |
Tilray TLRY |
$0.4278 3.3% |
3 |
 |
Canopy Growth CGC |
$1.31 2.2% |
3 |
 |
Aurora Cannabis ACB |
$4.85 2.1% |
4 |
 |
Sundial Growers SNDL |
$1.29 1.5% |
4 |
News
DVAX Alternative Data
Web Traffic
Dynavax Technologies receives an estimated 5958 monthly visitors to dynavax.com, which is up by 22.5% over the last month.
-
Web Traffic
5958
-
Change from Previous Month
22.5%
-
3 Month Change
50.8%
-
YoY Change
50.8%
Twitter Followers
Dynavax Technologies has 790 Twitter Followers on its main Twitter (also known as X) account.
-
Twitter Followers
790
-
Daily Change
0.1%
-
1 Month Change
0%
-
3 Month Change
0.1%
LinkedIn Followers
15,986 are following Dynavax Technologies on LinkedIn, up by 0.9% over the last month.
-
LinkedIn Followers
15986
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
2.7%
Job Postings
Dynavax Technologies currenly has an estimated 3 open job postings, up by 50% over the last month.
-
Job Postings
3
-
Daily Change
0%
-
1 Month Change
50%
-
3 Month Change
50%
LinkedIn Employees
According to LinkedIn, Dynavax Technologies has 340 employees, down by -1.2% over the last month.
-
LinkedIn Employees
340
-
Daily Change
0%
-
1 Month Change
1.2%
-
3 Month Change
0.6%
Reddit Mentions
Dynavax Technologies has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
News Mentions
Dynavax Technologies was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Dynavax Technologies is 78 out of 100 (bullish).
-
Business Outlook
78
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
DVAX Financials
DVAX Key Metrics
-
Total Revenue
$72M
-
Net Income
$7.1M
-
Earnings per Share
$0.0551
-
Free cash flow
$49.5M
-
EBITDA
$12.3M
-
EBITDA Ratio
0.170299
-
Total Assets
$986.3M
DVAX 2-year Revenue & Income
DVAX 2-year Free Cash Flow
DVAX Technicals
DVAX SMA
DVAX RSI
FAQ
What's the current price of Dynavax Technologies (DVAX) Stock?
The price of an Dynavax Technologies (DVAX) share is $9.41.
What's the market cap of Dynavax Technologies?
The current market cap of Dynavax Technologies is 1.1B.
Should I buy or sell DVAX?
Dynavax Technologies shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Dynavax Technologies is better viewed as a hold or accumulate position while waiting for further developments.
Is Dynavax Technologies a good investment?
The current analysis of Dynavax Technologies' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Dynavax Technologies' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Dynavax Technologies (DVAX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Dynavax Technologies stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Dynavax Technologies (DVAX) that investors often compare it to?
Dynavax Technologies (DVAX) is often compared to similar stocks such as TherapeuticsMD, Tilray, Canopy Growth, Aurora Cannabis and Sundial Growers.
What is the forecast for Dynavax Technologies' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Dynavax Technologies' stock price to be around $9.81 in 2026. Starting from the current price of $9.41, this represents a 4.3% change in price, indicating a neutral outlook for the stock.
How to buy Dynavax Technologies (DVAX) Stock?
Dynavax Technologies stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Dynavax Technologies shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.